Ehlers-Danlos syndrome (EDS) is a clinically and genetically heterogeneous group of heritable connective tissue disorders (HCTDs) defined by joint laxity, skin alterations, and joint hypermobility. The latest EDS classification recognized 13 subtypes in which the clinical and genetic phenotypes are often overlapping, making the diagnosis rather difficult and strengthening the importance of the molecular diagnostic confirmation. New genetic techniques such as next-generation sequencing (NGS) gave the opportunity to identify the genetic bases of unresolved EDS types and support clinical counseling. To date, the molecular defects have been identified in 19 genes, mainly in those encoding collagen, its modifying enzymes or other constituents of the extracellular matrix (ECM). In this review we summarize the contribution of NGS technologies to the current knowledge of the genetic background in different EDS subtypes

Cortini, F., Villa, C., Marinelli, B., Combi, R., Pesatori, A., Bassotti, A. (2019). Understanding the basis of Ehlers-Danlos syndrome in the era of the next-generation sequencing. ARCHIVES OF DERMATOLOGICAL RESEARCH, 311(4), 265-275 [10.1007/s00403-019-01894-0].

Understanding the basis of Ehlers-Danlos syndrome in the era of the next-generation sequencing

Villa, C;Combi, R;
2019

Abstract

Ehlers-Danlos syndrome (EDS) is a clinically and genetically heterogeneous group of heritable connective tissue disorders (HCTDs) defined by joint laxity, skin alterations, and joint hypermobility. The latest EDS classification recognized 13 subtypes in which the clinical and genetic phenotypes are often overlapping, making the diagnosis rather difficult and strengthening the importance of the molecular diagnostic confirmation. New genetic techniques such as next-generation sequencing (NGS) gave the opportunity to identify the genetic bases of unresolved EDS types and support clinical counseling. To date, the molecular defects have been identified in 19 genes, mainly in those encoding collagen, its modifying enzymes or other constituents of the extracellular matrix (ECM). In this review we summarize the contribution of NGS technologies to the current knowledge of the genetic background in different EDS subtypes
Articolo in rivista - Review Essay
Ehlers–Danlos syndrome; Heritable connective tissue disorders; Heterogeneity;
English
2-mar-2019
2019
311
4
265
275
none
Cortini, F., Villa, C., Marinelli, B., Combi, R., Pesatori, A., Bassotti, A. (2019). Understanding the basis of Ehlers-Danlos syndrome in the era of the next-generation sequencing. ARCHIVES OF DERMATOLOGICAL RESEARCH, 311(4), 265-275 [10.1007/s00403-019-01894-0].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/221125
Citazioni
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 12
Social impact